The Initial Therapeutic Response in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Contributes to the Change of Liver Function during Treatment: A Multicenter Analysis

Oncology (Switzerland) · Published 2026-05-11 · DOI 10.1159/000552397

Authors (22)

Takanori Suzuki, Ryo Sato, Kentaro Matsuura, Daisuke Kato, Katsumi Hayashi, Kohei Okayama, Fumihiro Okumura, Satoshi Sobue, Atsunori Kusakabe, Izumi Hasegawa, Kiyoto Narita, Tsutomu Mizoshita, Yoshihide Kimura, Hiromu Kondo, Hisayo Kojima, Kazuki Hayashi, Atsushi Ozasa, Hayato Kawamura, Kei Fujiwara, Shunsuke Nojiri, Hiromi Kataoka, Sakurayama Liver Study Group (SLSG)

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Suzuki, T., Sato, R., Matsuura, K., et al. (2026). The Initial Therapeutic Response in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Contributes to the Change of Liver Function during Treatment: A Multicenter Analysis. Oncology (Switzerland). https://doi.org/10.1159/000552397

Related articles

• Association of Hypoglycemic Agents with the Risk of Platinum-Based Chemotherapy-Induced Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus · Oncology (Switzerland) · 2026 · Same journal
• Multicenter Study on the Safety and Efficacy of First-Line Nivolumab-Combination Chemotherapy in Patients Aged 75 Years and Older with Unresectable Advanced or Recurrent Gastric Cancer · Oncology (Switzerland) · 2026 · Same journal
• Prognostic Effect of Preoperative Albumin-to-Globulin Ratio in Patients with Non-Metastatic Bladder Cancer Undergoing Radical Cystectomy · Oncology (Switzerland) · 2026 · Same journal
• Sex Differences in Cardiotoxicity of Anaplastic Lymphoma Kinase Inhibitors: An Analysis of the FDA Adverse Event Reporting System · Oncology (Switzerland) · 2025 · Same journal
• Weight Variations during First-Line Systemic Treatment of Metastatic Non-Small Cell Lung Cancer: New Paradigms from Real-World Data · Oncology (Switzerland) · 2026 · Same journal
• Evolving Therapeutic Landscape in Non–Muscle-Invasive Bladder Cancer (NMIBC) · Oncology (Switzerland) · 2026 · Same journal
• Lymphatic Metastasis Predicts Better Response to Nivolumab in Recurrent or Metastatic Gastric Cancer: Insights from Tumor-Draining Lymph Node Immunity and Long-Term Outcomes · Oncology (Switzerland) · 2025 · Same journal
• Emergency Department Visits After Radiotherapy in Patients with Solid Malignancies: Analysis of Causality and Severity · Oncology (Switzerland) · 2026 · Same journal
• Hyperthermic Intrathoracic Chemotherapy and Photodynamic Therapy: A Single-Institution Experience for Malignant Pleural Diseases · Oncology (Switzerland) · 2025 · Same journal
• Safety and Treatment Continuity of Switching between CDK4/6 Inhibitors for Metastatic Breast Cancer due to Adverse Events: An Exploratory Single-Center Study in Japan · Oncology (Switzerland) · 2025 · Same journal